Purification and Quality Control of Recombinant Septin Complexes for Cell-Free Reconstitution.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
23 06 2022
Historique:
entrez: 11 7 2022
pubmed: 12 7 2022
medline: 14 7 2022
Statut: epublish

Résumé

Septins are a family of conserved eukaryotic GTP-binding proteins that can form cytoskeletal filaments and higher-order structures from hetero-oligomeric complexes. They interact with other cytoskeletal components and the cell membrane to participate in important cellular functions such as migration and cell division. Due to the complexity of septins' many interactions, the large number of septin genes (13 in humans), and the ability of septins to form hetero-oligomeric complexes with different subunit compositions, cell-free reconstitution is a vital strategy to understand the basics of septin biology. The present paper first describes a method to purify recombinant septins in their hetero-oligomeric form using a two-step affinity chromatography approach. Then, the process of quality control used to check for the purity and integrity of the septin complexes is detailed. This process combines native and denaturing gel electrophoresis, negative stain electron microscopy, and interferometric scattering microscopy. Finally, a description of the process to check for the polymerization ability of septin complexes using negative stain electron microscopy and fluorescent microscopy is given. This demonstrates that it is possible to produce high-quality human septin hexamers and octamers containing different isoforms of septin_9, as well as Drosophila septin hexamers.

Identifiants

pubmed: 35815970
doi: 10.3791/63871
doi:

Substances chimiques

Protein Isoforms 0
GTP-Binding Proteins EC 3.6.1.-
Septins EC 3.6.1.-

Types de publication

Journal Article Video-Audio Media Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Gerard Castro-Linares (G)

Department of Bionanoscience, Kavli Institute of Nanoscience Delft, Delft University of Technology.

Jeffrey den Haan (J)

Department of Bionanoscience, Kavli Institute of Nanoscience Delft, Delft University of Technology.

Francois Iv (F)

Institut Fresnel, CNRS UMR7249, Aix Marseille Univ, Centrale Marseille.

Carla Silva Martins (C)

Institut Fresnel, CNRS UMR7249, Aix Marseille Univ, Centrale Marseille.

Aurélie Bertin (A)

Institut Curie, Université PSL, Sorbonne Université; Aurelie.Bertin@curie.fr.

Manos Mavrakis (M)

Institut Fresnel, CNRS UMR7249, Aix Marseille Univ, Centrale Marseille; manos.mavrakis@fresnel.fr.

Gijsje H Koenderink (GH)

Department of Bionanoscience, Kavli Institute of Nanoscience Delft, Delft University of Technology; G.H.Koenderink@tudelft.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH